Elevated p70S6K phosphorylation in rat soleus muscle during the early stage of unloading: Causes and consequences

Arch Biochem Biophys. 2019 Oct 15:674:108105. doi: 10.1016/j.abb.2019.108105. Epub 2019 Sep 10.

Abstract

Currently, there is a lack of investigation into the initial signaling events underlying the development of disuse muscle atrophy. The study was aimed to (i) identify an assumed relationship between AMPK dephosphorylation and p70S6K hyperphosphorylation in the initial period of hindlimb unloading (HS), and (ii) assess the signaling consequences of p70S6K hyperphosphorylation following 24-h HS. For experiment 1, rats were treated with AMPK activator (AICAR) for 6 d before HS as well as during 24-h HS. For experiment 2, rats were treated with mTORC1 inhibitor rapamycin during 24-h HS. The key signaling markers implicated in protein turnover were assessed using WB and RT-PCR. One-day HS resulted in a significant upregulation of MuRF-1 and MAFbx expression, increase in p70S6K (Thr389) and IRS-1 (Ser639) phosphorylation and a significant decrease in phosphorylated AMPK, AKT, FOXO3, total IRS-1 content, and HDAC5 nuclear content. AMPK and p70S6K phosphorylation did not differ from control in AICAR-treated unloaded rats. Rapamycin treatment during unloading abolished p70S6K and E3 ligases upregulation and increased HDAC5 nuclear accumulation. The results of the study suggest that mTORC-1/p70S6K signaling pathway in rat soleus muscle is activated following 24-h mechanical unloading. This activation is facilitated by a decrease in AMPK phosphorylation. Increased p70S6K activity at the initial stage of hindlimb unloading could lead to the upregulation of E3 ligases MAFbx/atrogin-1 and MuRF-1 via nuclear export of HDAC5.

Keywords: AMPK; E3 ubiquitin ligases; HDAC5; Hindlimb unloading; Soleus muscle; p70S6K.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / chemistry
  • AMP-Activated Protein Kinases / metabolism
  • Aminoimidazole Carboxamide / analogs & derivatives
  • Aminoimidazole Carboxamide / pharmacology
  • Animals
  • Enzyme Activators / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Hindlimb Suspension
  • Histone Deacetylases / metabolism
  • Male
  • Mechanistic Target of Rapamycin Complex 1 / antagonists & inhibitors
  • Muscle, Skeletal / metabolism*
  • Phosphorylation / drug effects
  • Rats, Wistar
  • Ribonucleotides / pharmacology
  • Ribosomal Protein S6 Kinases, 70-kDa / chemistry
  • Ribosomal Protein S6 Kinases, 70-kDa / metabolism*
  • Sirolimus / pharmacology
  • Threonine / chemistry
  • Ubiquitin-Protein Ligases / metabolism
  • Up-Regulation

Substances

  • Enzyme Activators
  • Enzyme Inhibitors
  • Ribonucleotides
  • Threonine
  • Aminoimidazole Carboxamide
  • Ubiquitin-Protein Ligases
  • Mechanistic Target of Rapamycin Complex 1
  • Ribosomal Protein S6 Kinases, 70-kDa
  • AMP-Activated Protein Kinases
  • Hdac5 protein, rat
  • Histone Deacetylases
  • AICA ribonucleotide
  • Sirolimus